Structure

Physi-Chem Properties

Molecular Weight:  553.38
Volume:  590.783
LogP:  5.507
LogD:  4.649
LogS:  -3.96
# Rotatable Bonds:  4
TPSA:  57.77
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  8
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.356
Synthetic Accessibility Score:  4.878
Fsp3:  0.6
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.506
MDCK Permeability:  8.279307621705811e-06
Pgp-inhibitor:  0.789
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.056
20% Bioavailability (F20%):  0.94
30% Bioavailability (F30%):  0.01

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.531
Plasma Protein Binding (PPB):  89.84196472167969%
Volume Distribution (VD):  2.814
Pgp-substrate:  8.064675331115723%

ADMET: Metabolism

CYP1A2-inhibitor:  0.025
CYP1A2-substrate:  0.846
CYP2C19-inhibitor:  0.092
CYP2C19-substrate:  0.977
CYP2C9-inhibitor:  0.021
CYP2C9-substrate:  0.244
CYP2D6-inhibitor:  0.435
CYP2D6-substrate:  0.934
CYP3A4-inhibitor:  0.078
CYP3A4-substrate:  0.937

ADMET: Excretion

Clearance (CL):  9.212
Half-life (T1/2):  0.128

ADMET: Toxicity

hERG Blockers:  0.878
Human Hepatotoxicity (H-HT):  0.951
Drug-inuced Liver Injury (DILI):  0.833
AMES Toxicity:  0.342
Rat Oral Acute Toxicity:  0.543
Maximum Recommended Daily Dose:  0.987
Skin Sensitization:  0.518
Carcinogencity:  0.19
Eye Corrosion:  0.003
Eye Irritation:  0.005
Respiratory Toxicity:  0.895

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC183407

Natural Product ID:  NPC183407
Common Name*:   Isostrychnopentamine
IUPAC Name:   (2R,3R,12bS)-3-ethyl-11-[(2S)-1-methylpyrrolidin-2-yl]-2-[[(1S)-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]methyl]-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-10-ol
Synonyms:   Isostrychnopentamine
Standard InCHIKey:  MHIOYLXTHAIJLU-FVHQJPTNSA-N
Standard InCHI:  InChI=1S/C35H47N5O/c1-4-21-20-40-17-14-26-24-11-12-31(41)32(28-10-7-15-38(28)2)35(24)37-34(26)30(40)19-22(21)18-29-33-25(13-16-39(29)3)23-8-5-6-9-27(23)36-33/h5-6,8-9,11-12,21-22,26,28-30,34,36-37,41H,4,7,10,13-20H2,1-3H3/t21-,22-,26?,28-,29-,30-,34?/m0/s1
SMILES:  CC[C@H]1CN2CCC3C([C@@H]2C[C@@H]1C[C@@H]1N(C)CCc2c1[nH]c1c2cccc1)Nc1c3ccc(c1[C@@H]1CCCN1C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL496076
PubChem CID:   44559861
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0001140] Harmala alkaloids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18713 Strychnos usambarensis Species Loganiaceae Eukaryota roots n.a. n.a. PMID[10217724]
NPO18713 Strychnos usambarensis Species Loganiaceae Eukaryota n.a. n.a. n.a. PMID[12398531]
NPO18713 Strychnos usambarensis Species Loganiaceae Eukaryota n.a. n.a. n.a. PMID[19299148]
NPO18713 Strychnos usambarensis Species Loganiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO18713 Strychnos usambarensis Species Loganiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO18713 Strychnos usambarensis Species Loganiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT393 Cell Line HCT-116 Homo sapiens IC50 = 7470.0 nM PMID[564937]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 104.0 nM PMID[564937]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 120.0 nM PMID[564937]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 152.0 nM PMID[564937]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC90 = 386.0 nM PMID[564937]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC90 = 450.0 nM PMID[564937]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC90 = 628.0 nM PMID[564937]
NPT2 Others Unspecified Ratio IC50 = 49.1 n.a. PMID[564937]
NPT2 Others Unspecified Ratio IC50 = 62.3 n.a. PMID[564937]
NPT2 Others Unspecified Ratio IC50 = 71.8 n.a. PMID[564937]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 0.0 nM PMID[564938]
NPT992 Organism Entamoeba histolytica Entamoeba histolytica IC50 = 10.39 ug.mL-1 PMID[564939]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC183407 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9303 High Similarity NPC162748
0.8873 High Similarity NPC477861
0.8614 High Similarity NPC476116
0.8416 Intermediate Similarity NPC469734
0.8404 Intermediate Similarity NPC470126
0.84 Intermediate Similarity NPC249040
0.8394 Intermediate Similarity NPC94943
0.8364 Intermediate Similarity NPC253580
0.8342 Intermediate Similarity NPC190007
0.8325 Intermediate Similarity NPC476041
0.8325 Intermediate Similarity NPC304926
0.829 Intermediate Similarity NPC212535
0.8213 Intermediate Similarity NPC475422
0.8204 Intermediate Similarity NPC87755
0.8182 Intermediate Similarity NPC469592
0.8182 Intermediate Similarity NPC471080
0.8135 Intermediate Similarity NPC72980
0.8131 Intermediate Similarity NPC280272
0.8116 Intermediate Similarity NPC475910
0.8102 Intermediate Similarity NPC2497
0.8061 Intermediate Similarity NPC472294
0.8039 Intermediate Similarity NPC329747
0.8028 Intermediate Similarity NPC469594
0.8021 Intermediate Similarity NPC474409
0.798 Intermediate Similarity NPC70956
0.798 Intermediate Similarity NPC153042
0.798 Intermediate Similarity NPC243834
0.7965 Intermediate Similarity NPC81939
0.7962 Intermediate Similarity NPC294620
0.7934 Intermediate Similarity NPC330009
0.793 Intermediate Similarity NPC475666
0.7917 Intermediate Similarity NPC477532
0.79 Intermediate Similarity NPC6215
0.7885 Intermediate Similarity NPC475070
0.7874 Intermediate Similarity NPC475085
0.7874 Intermediate Similarity NPC291535
0.7874 Intermediate Similarity NPC475112
0.7867 Intermediate Similarity NPC126066
0.785 Intermediate Similarity NPC46580
0.7848 Intermediate Similarity NPC325976
0.7835 Intermediate Similarity NPC472123
0.7824 Intermediate Similarity NPC193267
0.7824 Intermediate Similarity NPC213530
0.782 Intermediate Similarity NPC469589
0.7818 Intermediate Similarity NPC473185
0.7804 Intermediate Similarity NPC470549
0.7783 Intermediate Similarity NPC324149
0.7772 Intermediate Similarity NPC106833
0.7772 Intermediate Similarity NPC469497
0.7767 Intermediate Similarity NPC170114
0.7748 Intermediate Similarity NPC326363
0.7742 Intermediate Similarity NPC473179
0.7731 Intermediate Similarity NPC305984
0.7723 Intermediate Similarity NPC246700
0.7723 Intermediate Similarity NPC128751
0.7713 Intermediate Similarity NPC476451
0.7706 Intermediate Similarity NPC477533
0.77 Intermediate Similarity NPC11464
0.77 Intermediate Similarity NPC167860
0.77 Intermediate Similarity NPC123976
0.7696 Intermediate Similarity NPC99666
0.7689 Intermediate Similarity NPC470931
0.7677 Intermediate Similarity NPC88363
0.7675 Intermediate Similarity NPC81175
0.767 Intermediate Similarity NPC242209
0.767 Intermediate Similarity NPC70259
0.7668 Intermediate Similarity NPC209174
0.7662 Intermediate Similarity NPC471891
0.7656 Intermediate Similarity NPC267423
0.7656 Intermediate Similarity NPC476044
0.7655 Intermediate Similarity NPC295228
0.7644 Intermediate Similarity NPC474880
0.7644 Intermediate Similarity NPC221786
0.7642 Intermediate Similarity NPC193777
0.7634 Intermediate Similarity NPC477531
0.763 Intermediate Similarity NPC285558
0.7626 Intermediate Similarity NPC96890
0.7623 Intermediate Similarity NPC252251
0.7623 Intermediate Similarity NPC314954
0.7621 Intermediate Similarity NPC205934
0.7621 Intermediate Similarity NPC43787
0.7613 Intermediate Similarity NPC214980
0.7608 Intermediate Similarity NPC329793
0.7596 Intermediate Similarity NPC72211
0.7596 Intermediate Similarity NPC306376
0.7594 Intermediate Similarity NPC476106
0.7593 Intermediate Similarity NPC478074
0.759 Intermediate Similarity NPC317430
0.7588 Intermediate Similarity NPC232340
0.7588 Intermediate Similarity NPC41679
0.7583 Intermediate Similarity NPC223427
0.7565 Intermediate Similarity NPC478082
0.7565 Intermediate Similarity NPC477067
0.7562 Intermediate Similarity NPC472108
0.7562 Intermediate Similarity NPC139291
0.7556 Intermediate Similarity NPC475253
0.7548 Intermediate Similarity NPC77555
0.7546 Intermediate Similarity NPC48353
0.7544 Intermediate Similarity NPC473183
0.7537 Intermediate Similarity NPC171171
0.7534 Intermediate Similarity NPC303658
0.7534 Intermediate Similarity NPC264285
0.7534 Intermediate Similarity NPC319232
0.7534 Intermediate Similarity NPC24370
0.7533 Intermediate Similarity NPC473184
0.7525 Intermediate Similarity NPC84478
0.7523 Intermediate Similarity NPC152768
0.7523 Intermediate Similarity NPC469928
0.7523 Intermediate Similarity NPC148183
0.7513 Intermediate Similarity NPC229173
0.75 Intermediate Similarity NPC23294
0.7489 Intermediate Similarity NPC478081
0.7488 Intermediate Similarity NPC106937
0.7488 Intermediate Similarity NPC232727
0.7477 Intermediate Similarity NPC220851
0.7477 Intermediate Similarity NPC473362
0.7477 Intermediate Similarity NPC166492
0.7467 Intermediate Similarity NPC477608
0.7467 Intermediate Similarity NPC477607
0.7465 Intermediate Similarity NPC470500
0.7462 Intermediate Similarity NPC474897
0.7461 Intermediate Similarity NPC475990
0.7455 Intermediate Similarity NPC214142
0.7455 Intermediate Similarity NPC473041
0.7454 Intermediate Similarity NPC5145
0.7454 Intermediate Similarity NPC303951
0.7452 Intermediate Similarity NPC131017
0.7446 Intermediate Similarity NPC477066
0.7443 Intermediate Similarity NPC74969
0.7441 Intermediate Similarity NPC11017
0.7438 Intermediate Similarity NPC204717
0.7437 Intermediate Similarity NPC329688
0.7437 Intermediate Similarity NPC189812
0.7436 Intermediate Similarity NPC17437
0.7435 Intermediate Similarity NPC470784
0.7432 Intermediate Similarity NPC310118
0.7431 Intermediate Similarity NPC477610
0.7427 Intermediate Similarity NPC469501
0.7427 Intermediate Similarity NPC469470
0.7422 Intermediate Similarity NPC304307
0.7422 Intermediate Similarity NPC34580
0.7422 Intermediate Similarity NPC124920
0.7422 Intermediate Similarity NPC261251
0.7422 Intermediate Similarity NPC118559
0.7418 Intermediate Similarity NPC476098
0.7418 Intermediate Similarity NPC162484
0.7416 Intermediate Similarity NPC472193
0.7414 Intermediate Similarity NPC473312
0.7411 Intermediate Similarity NPC21638
0.7402 Intermediate Similarity NPC314002
0.7391 Intermediate Similarity NPC184680
0.7389 Intermediate Similarity NPC472109
0.7389 Intermediate Similarity NPC100547
0.7389 Intermediate Similarity NPC19679
0.7389 Intermediate Similarity NPC220765
0.7389 Intermediate Similarity NPC472110
0.7387 Intermediate Similarity NPC259545
0.7387 Intermediate Similarity NPC471294
0.7384 Intermediate Similarity NPC153400
0.7381 Intermediate Similarity NPC232130
0.7378 Intermediate Similarity NPC202503
0.7361 Intermediate Similarity NPC210828
0.7361 Intermediate Similarity NPC86834
0.7359 Intermediate Similarity NPC470785
0.7357 Intermediate Similarity NPC95240
0.7357 Intermediate Similarity NPC223409
0.7357 Intermediate Similarity NPC322135
0.7352 Intermediate Similarity NPC475602
0.7349 Intermediate Similarity NPC472111
0.7346 Intermediate Similarity NPC265576
0.7336 Intermediate Similarity NPC473105
0.7336 Intermediate Similarity NPC473182
0.7336 Intermediate Similarity NPC323752
0.7336 Intermediate Similarity NPC53144
0.7327 Intermediate Similarity NPC201697
0.7327 Intermediate Similarity NPC209769
0.7325 Intermediate Similarity NPC14288
0.7322 Intermediate Similarity NPC478080
0.7321 Intermediate Similarity NPC16352
0.7317 Intermediate Similarity NPC15102
0.7313 Intermediate Similarity NPC33949
0.7311 Intermediate Similarity NPC476167
0.7309 Intermediate Similarity NPC195788
0.7309 Intermediate Similarity NPC237901
0.7309 Intermediate Similarity NPC132642
0.7297 Intermediate Similarity NPC477609
0.7293 Intermediate Similarity NPC54803
0.7293 Intermediate Similarity NPC321592
0.729 Intermediate Similarity NPC135887
0.729 Intermediate Similarity NPC199277
0.7289 Intermediate Similarity NPC211416
0.7286 Intermediate Similarity NPC195314
0.7286 Intermediate Similarity NPC326634
0.7281 Intermediate Similarity NPC39679
0.7277 Intermediate Similarity NPC473317
0.7277 Intermediate Similarity NPC471506
0.7273 Intermediate Similarity NPC473187
0.7273 Intermediate Similarity NPC473757
0.7269 Intermediate Similarity NPC476492
0.7269 Intermediate Similarity NPC110151

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC183407 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.798 Intermediate Similarity NPD7948 Phase 1
0.7902 Intermediate Similarity NPD8396 Approved
0.7902 Intermediate Similarity NPD8395 Approved
0.7839 Intermediate Similarity NPD6344 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD4511 Phase 1
0.7773 Intermediate Similarity NPD2916 Discontinued
0.7731 Intermediate Similarity NPD7823 Clinical (unspecified phase)
0.7696 Intermediate Similarity NPD8405 Clinical (unspecified phase)
0.7689 Intermediate Similarity NPD5658 Approved
0.7659 Intermediate Similarity NPD5575 Clinical (unspecified phase)
0.765 Intermediate Similarity NPD5522 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD3814 Phase 1
0.7641 Intermediate Similarity NPD1326 Approved
0.7641 Intermediate Similarity NPD1325 Approved
0.7596 Intermediate Similarity NPD7889 Clinical (unspecified phase)
0.756 Intermediate Similarity NPD4118 Clinical (unspecified phase)
0.7557 Intermediate Similarity NPD7221 Approved
0.7557 Intermediate Similarity NPD7219 Approved
0.755 Intermediate Similarity NPD8464 Clinical (unspecified phase)
0.7525 Intermediate Similarity NPD5065 Approved
0.7523 Intermediate Similarity NPD7112 Discontinued
0.7512 Intermediate Similarity NPD3003 Approved
0.75 Intermediate Similarity NPD7194 Discontinued
0.749 Intermediate Similarity NPD8363 Approved
0.749 Intermediate Similarity NPD8364 Approved
0.7488 Intermediate Similarity NPD6610 Clinical (unspecified phase)
0.7488 Intermediate Similarity NPD802 Phase 2
0.7452 Intermediate Similarity NPD6861 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD8358 Approved
0.7429 Intermediate Similarity NPD8365 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD7558 Phase 2
0.7382 Intermediate Similarity NPD2882 Phase 1
0.7376 Intermediate Similarity NPD8109 Clinical (unspecified phase)
0.7354 Intermediate Similarity NPD7726 Phase 1
0.7349 Intermediate Similarity NPD3932 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD8403 Phase 1
0.7315 Intermediate Similarity NPD3930 Clinical (unspecified phase)
0.7309 Intermediate Similarity NPD8466 Approved
0.7309 Intermediate Similarity NPD8465 Approved
0.7309 Intermediate Similarity NPD8467 Approved
0.7306 Intermediate Similarity NPD3330 Phase 1
0.7301 Intermediate Similarity NPD7603 Discontinued
0.726 Intermediate Similarity NPD5936 Approved
0.726 Intermediate Similarity NPD5939 Approved
0.7251 Intermediate Similarity NPD6449 Clinical (unspecified phase)
0.724 Intermediate Similarity NPD5903 Approved
0.724 Intermediate Similarity NPD5902 Approved
0.7235 Intermediate Similarity NPD6838 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD7222 Phase 2
0.723 Intermediate Similarity NPD1768 Approved
0.7207 Intermediate Similarity NPD6803 Clinical (unspecified phase)
0.7196 Intermediate Similarity NPD4601 Approved
0.7196 Intermediate Similarity NPD4600 Approved
0.7194 Intermediate Similarity NPD8460 Approved
0.7194 Intermediate Similarity NPD8426 Approved
0.7194 Intermediate Similarity NPD8459 Approved
0.7194 Intermediate Similarity NPD8425 Approved
0.7192 Intermediate Similarity NPD6159 Phase 2
0.719 Intermediate Similarity NPD3404 Approved
0.7189 Intermediate Similarity NPD5530 Phase 1
0.7181 Intermediate Similarity NPD4401 Phase 2
0.7181 Intermediate Similarity NPD4403 Phase 3
0.7176 Intermediate Similarity NPD4886 Phase 2
0.7172 Intermediate Similarity NPD5138 Approved
0.7172 Intermediate Similarity NPD5140 Approved
0.7171 Intermediate Similarity NPD8427 Approved
0.7171 Intermediate Similarity NPD7867 Phase 1
0.7171 Intermediate Similarity NPD8429 Approved
0.7171 Intermediate Similarity NPD8428 Approved
0.7168 Intermediate Similarity NPD6824 Clinical (unspecified phase)
0.7163 Intermediate Similarity NPD6141 Clinical (unspecified phase)
0.7163 Intermediate Similarity NPD2383 Phase 1
0.715 Intermediate Similarity NPD2177 Approved
0.715 Intermediate Similarity NPD2176 Approved
0.715 Intermediate Similarity NPD2175 Phase 3
0.7143 Intermediate Similarity NPD2380 Approved
0.7143 Intermediate Similarity NPD2382 Approved
0.7143 Intermediate Similarity NPD2381 Approved
0.7143 Intermediate Similarity NPD4885 Approved
0.7136 Intermediate Similarity NPD5744 Clinical (unspecified phase)
0.713 Intermediate Similarity NPD6975 Discontinued
0.713 Intermediate Similarity NPD5612 Discontinued
0.7123 Intermediate Similarity NPD3324 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD7947 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD1685 Approved
0.7121 Intermediate Similarity NPD1684 Approved
0.7118 Intermediate Similarity NPD7731 Approved
0.7118 Intermediate Similarity NPD7730 Approved
0.7113 Intermediate Similarity NPD6158 Phase 2
0.7113 Intermediate Similarity NPD6476 Clinical (unspecified phase)
0.7112 Intermediate Similarity NPD7789 Approved
0.7112 Intermediate Similarity NPD7951 Approved
0.7112 Intermediate Similarity NPD7790 Approved
0.7112 Intermediate Similarity NPD7952 Approved
0.7112 Intermediate Similarity NPD7791 Approved
0.7112 Intermediate Similarity NPD7950 Approved
0.7112 Intermediate Similarity NPD7953 Approved
0.7108 Intermediate Similarity NPD6203 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD6976 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD7271 Approved
0.7105 Intermediate Similarity NPD7586 Clinical (unspecified phase)
0.709 Intermediate Similarity NPD7955 Approved
0.709 Intermediate Similarity NPD7956 Approved
0.7085 Intermediate Similarity NPD8284 Discontinued
0.7081 Intermediate Similarity NPD8431 Approved
0.7073 Intermediate Similarity NPD8386 Phase 2
0.7067 Intermediate Similarity NPD6985 Discontinued
0.7064 Intermediate Similarity NPD4795 Phase 2
0.7056 Intermediate Similarity NPD7824 Approved
0.7054 Intermediate Similarity NPD6503 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD6965 Clinical (unspecified phase)
0.7043 Intermediate Similarity NPD6977 Clinical (unspecified phase)
0.7043 Intermediate Similarity NPD6978 Phase 2
0.7039 Intermediate Similarity NPD6595 Phase 3
0.7034 Intermediate Similarity NPD8017 Clinical (unspecified phase)
0.7034 Intermediate Similarity NPD8016 Phase 3
0.701 Intermediate Similarity NPD6492 Phase 2
0.7009 Intermediate Similarity NPD3127 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1392 Approved
0.7 Intermediate Similarity NPD7452 Approved
0.7 Intermediate Similarity NPD7453 Approved
0.6996 Remote Similarity NPD8093 Discontinued
0.6996 Remote Similarity NPD2794 Discontinued
0.6995 Remote Similarity NPD1038 Approved
0.6992 Remote Similarity NPD7729 Clinical (unspecified phase)
0.6986 Remote Similarity NPD5426 Phase 3
0.6981 Remote Similarity NPD5913 Phase 3
0.6981 Remote Similarity NPD5912 Clinical (unspecified phase)
0.698 Remote Similarity NPD7181 Phase 3
0.6972 Remote Similarity NPD3931 Approved
0.6972 Remote Similarity NPD3928 Approved
0.6971 Remote Similarity NPD5596 Phase 2
0.6968 Remote Similarity NPD7666 Phase 3
0.6968 Remote Similarity NPD7665 Phase 2
0.6968 Remote Similarity NPD6376 Discontinued
0.6967 Remote Similarity NPD8110 Clinical (unspecified phase)
0.6966 Remote Similarity NPD5040 Clinical (unspecified phase)
0.6964 Remote Similarity NPD8094 Discontinued
0.696 Remote Similarity NPD3402 Phase 1
0.6959 Remote Similarity NPD484 Approved
0.6955 Remote Similarity NPD7958 Clinical (unspecified phase)
0.6955 Remote Similarity NPD7957 Phase 1
0.6951 Remote Similarity NPD4502 Phase 2
0.6951 Remote Similarity NPD6220 Phase 3
0.6948 Remote Similarity NPD7803 Approved
0.693 Remote Similarity NPD5930 Phase 3
0.6926 Remote Similarity NPD7676 Clinical (unspecified phase)
0.6926 Remote Similarity NPD7674 Phase 3
0.6926 Remote Similarity NPD7675 Phase 3
0.6923 Remote Similarity NPD6290 Phase 2
0.6923 Remote Similarity NPD4204 Approved
0.6923 Remote Similarity NPD8322 Phase 2
0.6923 Remote Similarity NPD4203 Approved
0.6916 Remote Similarity NPD1304 Clinical (unspecified phase)
0.691 Remote Similarity NPD6968 Phase 2
0.691 Remote Similarity NPD6969 Phase 2
0.6905 Remote Similarity NPD2762 Phase 2
0.6905 Remote Similarity NPD6227 Discontinued
0.6898 Remote Similarity NPD7081 Clinical (unspecified phase)
0.6897 Remote Similarity NPD1921 Clinical (unspecified phase)
0.6894 Remote Similarity NPD8489 Phase 1
0.6893 Remote Similarity NPD6375 Clinical (unspecified phase)
0.6892 Remote Similarity NPD7671 Approved
0.6892 Remote Similarity NPD7672 Approved
0.6889 Remote Similarity NPD8488 Clinical (unspecified phase)
0.6888 Remote Similarity NPD4463 Approved
0.6888 Remote Similarity NPD4462 Approved
0.6883 Remote Similarity NPD6246 Approved
0.6881 Remote Similarity NPD1740 Approved
0.6881 Remote Similarity NPD5497 Clinical (unspecified phase)
0.6881 Remote Similarity NPD1739 Approved
0.6875 Remote Similarity NPD7470 Discontinued
0.6872 Remote Similarity NPD5164 Discontinued
0.687 Remote Similarity NPD8244 Phase 2
0.6867 Remote Similarity NPD7781 Approved
0.6867 Remote Similarity NPD7780 Approved
0.6863 Remote Similarity NPD4184 Clinical (unspecified phase)
0.6851 Remote Similarity NPD7796 Approved
0.6851 Remote Similarity NPD7797 Approved
0.6847 Remote Similarity NPD8493 Clinical (unspecified phase)
0.6844 Remote Similarity NPD8458 Clinical (unspecified phase)
0.6844 Remote Similarity NPD7594 Clinical (unspecified phase)
0.6839 Remote Similarity NPD4637 Clinical (unspecified phase)
0.6833 Remote Similarity NPD31 Approved
0.6833 Remote Similarity NPD4033 Approved
0.6833 Remote Similarity NPD5901 Discontinued
0.6833 Remote Similarity NPD32 Approved
0.6833 Remote Similarity NPD4039 Approved
0.6833 Remote Similarity NPD4122 Approved
0.6833 Remote Similarity NPD4036 Approved
0.6833 Remote Similarity NPD4037 Approved
0.6833 Remote Similarity NPD4038 Approved
0.6833 Remote Similarity NPD4034 Approved
0.6833 Remote Similarity NPD4035 Approved
0.6824 Remote Similarity NPD6327 Phase 1
0.682 Remote Similarity NPD7025 Clinical (unspecified phase)
0.6806 Remote Similarity NPD3017 Clinical (unspecified phase)
0.6806 Remote Similarity NPD6491 Clinical (unspecified phase)
0.6804 Remote Similarity NPD4500 Approved
0.6804 Remote Similarity NPD4501 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data